The board appointed Mr. Ross Haghighat as Co-Chief Executive Officer of Epiphany Technology Acquisition Corp., effective September 16, 2022. Ross Haghighat has served as Chief Executive Officer, Chief Financial Officer and a Director of BioPlus Acquisition Corp. since December 2021.

Mr. Haghighat is the founding partner at Jasper Capital Partners and Chairman of Triton Systems Inc. Mr. Haghighat has been a founder, co-founder, and board member of more than a dozen private and public technology companies in the US, Europe, China and Australia. During Mr. Haghighat's expansive career as an operator, he generated billions in shareholder value through his roles transforming companies from early-stage technology firms to successful corporations, as well as integrated divisions of Fortune 500 companies. From 1994 to 2001, Mr. Haghighat co-founded and led CoreTek Inc. Mr. Haghighat currently serves on the Board of Directors at Chinook Therapeutics Inc., where Mr. Haghighat is Chairman of the Transaction Committee; CITIC Capital Acquisition Corp., where Mr. Haghighat also serves as Chair of the Audit Committee of Fluence Corporation Ltd., where Mr. Haghighat serves as Vice Chairman; Angel Medical Systems Inc., where Mr. Haghighat serves as Lead Director and FRX Polymers Inc., where Mr. Haghighat serves as Chairman.

Mr. Haghighat received a Bachelor of Science in Advanced Materials Engineering from Rutgers University and Master of Science in Organometalic Chemistry from Rutgers University, as well as an MBA from Boston College — Wallace E Carroll School of Management. Mr. Haghighat is well qualified to serve on the Board due to his extensive operating, investing and board experience in the biotechnology industry.